Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161569087> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W3161569087 endingPage "2168" @default.
- W3161569087 startingPage "2168" @default.
- W3161569087 abstract "Pachychoroid neovasculopathy (PNV) is treated with antivascular endothelial growth factor (VEGF) injection and photodynamic therapy (PDT), but no curative treatment has yet been established. We aimed to clarify the treatment results of a reduced dose of PDT for PNV. The subjects were 27 eyes of 27 patients (male:female = 20:7, mean age 58.9 years). PDT, at 2/3 of the conventional dose (2/3PDT), was administered once. The patients were then observed for one year. Eyes with polypoidal choroidal vasculopathy (PCV) were excluded. We investigated the associations among the central retinal thickness, choroidal thickness, and visual acuity changes before treatment and one, three, six and 12 months after PDT. When serous retinal detachment was increased or unchanged or new hemorrhages were observed, as compared with pretreatment findings, intravitreal injection of an anti-VEGF agent was performed. Visual acuity was significantly improved, as compared to before treatment, at three, six, and 12 months after 2/3PDT. Foveal retinal thickness was significantly decreased after versus before treatment in the 2/3PDT group (p < 0.001). Foveal choroidal thickness was also significantly reduced in the 2/3PDT group (p = 0.001). Additional intravitreal anti-VEGF agent injections were administered to three patients (11%), while 24 (89%) required no additional treatment during the one-year follow-up period. For PNV without polyps, 2/3PDT appears to be effective." @default.
- W3161569087 created "2021-05-24" @default.
- W3161569087 creator A5007291178 @default.
- W3161569087 creator A5019881386 @default.
- W3161569087 creator A5028668037 @default.
- W3161569087 creator A5066449873 @default.
- W3161569087 creator A5069874619 @default.
- W3161569087 creator A5084684329 @default.
- W3161569087 date "2021-05-17" @default.
- W3161569087 modified "2023-09-29" @default.
- W3161569087 title "Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy" @default.
- W3161569087 cites W1481983591 @default.
- W3161569087 cites W1968443666 @default.
- W3161569087 cites W2004340336 @default.
- W3161569087 cites W2006093387 @default.
- W3161569087 cites W2021661373 @default.
- W3161569087 cites W2025287737 @default.
- W3161569087 cites W2150416945 @default.
- W3161569087 cites W2303207774 @default.
- W3161569087 cites W2320279835 @default.
- W3161569087 cites W2320636939 @default.
- W3161569087 cites W2580476816 @default.
- W3161569087 cites W2735194804 @default.
- W3161569087 cites W2790202676 @default.
- W3161569087 cites W2807685243 @default.
- W3161569087 cites W2809745482 @default.
- W3161569087 cites W2887872549 @default.
- W3161569087 cites W2914154706 @default.
- W3161569087 cites W2916678270 @default.
- W3161569087 cites W3003189331 @default.
- W3161569087 cites W3014212504 @default.
- W3161569087 cites W4211027220 @default.
- W3161569087 cites W4232841428 @default.
- W3161569087 doi "https://doi.org/10.3390/jcm10102168" @default.
- W3161569087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8155862" @default.
- W3161569087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34067863" @default.
- W3161569087 hasPublicationYear "2021" @default.
- W3161569087 type Work @default.
- W3161569087 sameAs 3161569087 @default.
- W3161569087 citedByCount "4" @default.
- W3161569087 countsByYear W31615690872022 @default.
- W3161569087 countsByYear W31615690872023 @default.
- W3161569087 crossrefType "journal-article" @default.
- W3161569087 hasAuthorship W3161569087A5007291178 @default.
- W3161569087 hasAuthorship W3161569087A5019881386 @default.
- W3161569087 hasAuthorship W3161569087A5028668037 @default.
- W3161569087 hasAuthorship W3161569087A5066449873 @default.
- W3161569087 hasAuthorship W3161569087A5069874619 @default.
- W3161569087 hasAuthorship W3161569087A5084684329 @default.
- W3161569087 hasBestOaLocation W31615690871 @default.
- W3161569087 hasConcept C118487528 @default.
- W3161569087 hasConcept C126322002 @default.
- W3161569087 hasConcept C150173356 @default.
- W3161569087 hasConcept C178790620 @default.
- W3161569087 hasConcept C185592680 @default.
- W3161569087 hasConcept C2778257484 @default.
- W3161569087 hasConcept C2780827179 @default.
- W3161569087 hasConcept C2781323092 @default.
- W3161569087 hasConcept C71924100 @default.
- W3161569087 hasConceptScore W3161569087C118487528 @default.
- W3161569087 hasConceptScore W3161569087C126322002 @default.
- W3161569087 hasConceptScore W3161569087C150173356 @default.
- W3161569087 hasConceptScore W3161569087C178790620 @default.
- W3161569087 hasConceptScore W3161569087C185592680 @default.
- W3161569087 hasConceptScore W3161569087C2778257484 @default.
- W3161569087 hasConceptScore W3161569087C2780827179 @default.
- W3161569087 hasConceptScore W3161569087C2781323092 @default.
- W3161569087 hasConceptScore W3161569087C71924100 @default.
- W3161569087 hasIssue "10" @default.
- W3161569087 hasLocation W31615690871 @default.
- W3161569087 hasLocation W31615690872 @default.
- W3161569087 hasLocation W31615690873 @default.
- W3161569087 hasOpenAccess W3161569087 @default.
- W3161569087 hasPrimaryLocation W31615690871 @default.
- W3161569087 hasRelatedWork W1841896533 @default.
- W3161569087 hasRelatedWork W2017154879 @default.
- W3161569087 hasRelatedWork W2077389784 @default.
- W3161569087 hasRelatedWork W2080677442 @default.
- W3161569087 hasRelatedWork W2093080026 @default.
- W3161569087 hasRelatedWork W2304355963 @default.
- W3161569087 hasRelatedWork W2321393137 @default.
- W3161569087 hasRelatedWork W2495196031 @default.
- W3161569087 hasRelatedWork W2605504011 @default.
- W3161569087 hasRelatedWork W2948748427 @default.
- W3161569087 hasVolume "10" @default.
- W3161569087 isParatext "false" @default.
- W3161569087 isRetracted "false" @default.
- W3161569087 magId "3161569087" @default.
- W3161569087 workType "article" @default.